Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species

References

1. Adam M., Lepottier M. F., Eloit M. 1994; Vaccination of pigs with replication defective adenovirus: the example of pseudorabies. Veterinary Microbiology in press
   [Google Scholar]
2. Andersson M., Paabo S., Nilsson T., Peterson P. A. 1985; Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215–222
   [Google Scholar]
3. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L. D., Poenaru L., Perricaudet M., Kahn A., Peschanski M. R. 1993; Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genetics 3:224–228
   [Google Scholar]
4. Betts A. O., Jennings A. R., Lamont P. H., Page Z. 1962; Inoculation of pigs with adenovirus of man. Nature; London: 19345–46
   [Google Scholar]
5. Caillaud C., Akli S., Vigne E., Koulakoff A., Perricaudet M., Poenaru L., Kahn A., Berwald-Netter Y. 1993; Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. European Journal of Neurosciences 5:1287–1291
   [Google Scholar]
6. Cough R. B., Chanock R. M., Cate T. R., Lang D. J., Knight V., Huebner R. J. 1963; Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. American Review of Respiratory Disease 88:394–403
   [Google Scholar]
7. Eloit M., Gilardi-Hebestreit P., Toma B., Perricaudet M. 1990; Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. Journal of General Virology 71:2425–2431
   [Google Scholar]
8. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S. M., Chanock R. M., Prince G. A. 1989; Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of Sciences, U.S.A 86:3823–3827
   [Google Scholar]
9. Ginsberg H. S., Moldawer L. L., Sehgal P. B., Redington M., Kilian P. L., Chanock R. M., Prince G. A. 1991; A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proceedings of the National Academy of Sciences, U.S.A 88:1651–1655
   [Google Scholar]
10. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
11. Guzman R. J., Lemarchand P., Crystal R. G., Epstein S. E., Finkel T. 1993; Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circulation Research 73:1202–1207
    [Google Scholar]
12. Haddada H., Lopez M., Martinache C., Ragot T., Abina M. A., Perricaudet M. 1993; Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochemical and Biophysical Research Communications 195:1174–1183
    [Google Scholar]
13. Jaffe H. A., Danel C., Longenecker G., Metzger M., Setoguchi Y., Rosenfeld M. A., Gant T. W., Thorgeirsson S. S., Stratford-Perricaudet L. D., Perricaudet M. 1992; Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genetics 1:372–378
    [Google Scholar]
14. Jones N., Shenk T. 1978; Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13:181–188
    [Google Scholar]
15. Le Gal La Salle G., Robert J. J., Berrard S., Ridoux V., Stratford-Perricaudet L. D., Perricaudet M., Mallet J. 1993; An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988–990
    [Google Scholar]
16. Pacini D. L., Dubovi E. J., Clyde W. A. 1974; A new animal model for human respiratory tract disease due to adenovirus. Journal of Infectious Diseases 150:92–97
    [Google Scholar]
17. Prevec L., Schneider M., Rosenthal K. L., Belbeck L. W., Derbyshire J. B., Graham F. L. 1989; Use of human adenovirus-based vectors for antigen expression in animals. Journal of General Virology 70:429–434
    [Google Scholar]
18. Prince G. A., Porter D. D., Jenson A. B., Horswood R. L., Chanock R. M., Ginsberg H. S. 1993; Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). Journal of Virology 67:101–111
    [Google Scholar]
19. Ragot T., Finerty S., Watkins P. E., Perricaudet M., Morgan A. J. 1993a; Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. Journal of General Virology 74:501–507
    [Google Scholar]
20. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J. C., Perricaudet M. 1993b; Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature; London: 361647–650
    [Google Scholar]
21. Schneider M. D., French B. A. 1993; The advent of adenovirus-gene therapy for cardiovascular disease. Circulation 88:1937–1942
    [Google Scholar]
22. Schwartz A. R., Togo Y., Hornick R. B. 1974; Clinical evaluation of live, oral types 1, 2 and 5 adenovirus vaccines. American Review of Respiratory Disease 109:233–238
    [Google Scholar]
23. Stratford-Perricaudet L., Perricaudet M. 1991; Gene transfer into animals: the promise of adenovirus. In Human Gene Transfer pp. 51–61 Cohen-Haguenauer O., Boiron M. Edited by Montrouge: John Libbey Eurotext;
    [Google Scholar]
24. Thimmapaya B., Jones N., Shenk T. 1982; Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543–551
    [Google Scholar]
25. Top F. H., Grossman R. A., Bartelloni P. J., Segal H. E., Dudding B. A., Russell P. K., Buscher E. L. 1971a; Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. Journal of Infectious Diseases 124:148–154
    [Google Scholar]
26. Top F. H., Buscher E. L., Bancroft W. H., Russell P. K. 1971b; Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. Journal of Infectious Diseases 124:155–160
    [Google Scholar]
27. Wesseling J. G., Godeke G.-J., Schijns V. E. C. J., Prevec L., Graham F. L., Horzinek M. C., Rottier P. J. M. 1993; Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. Journal of General Virology 74:2061–2069
    [Google Scholar]